Effect of Huanglian-jie-du decoction for somatic symptoms and insomnia in patients with Hwa-byung: a randomized controlled trial

Kyung Hee University Oriental Medical Center0 个研究点目标入组 44 人开始时间: 待定最近更新: 2021年1月28日

适应症

试验速览

暂无简介。

•1. Patients who are evaluated as high risk of suicide
•2. Patients who suffer current or lifetime Bipolar disorder, Schizophrenia
•3. Patients who take excluded therapy within these days.
•a. take all psychotropic within 30 days on screening day(ex. antidepressant, anxiolytic, antipsychotic)
•b. take non-psychopharmacologocal drugs that have psychotropic effect within 14 days on screening day
•c. take all psychotherapy within 30 days on screening day
•d. take electroshock treatment, transcranial magnetic therapy within 30 days on screening day
•e. take all oriental medical treatment for depression within 14 days on screening day
•4. Patients who have serious unstable medical condition.
•5. Diabetic patients not controlled by hypoglycemic agents or insulin.
•6. Systolic blood pressure > 160 mmHg or diastolic blood pressure > 95 mmHg.
•7. Alanine aminotransferase(ALT) and aspartate aminotransferase(AST) levels 1.5 times as high as or higher than the normal upper limit
•8. Blood urea nitrogen (BUN) and creatinine (Cr) levels 1.5 times as high as or higher than the normal upper limit
•9. Patients who had abnormality on lab study with Hwabyung (ex. hyperthroidism, hypothyrodism)
•10. Women during pregnancy, lactation, or those who are likely to have been pregnant without proper contraception.

发起方

Kyung Hee University Oriental Medical Center